NAN vs PCK

ASX Healthcare sector comparison — updated 14 Jul 2026 — Healthcare sector

NAN

NANOSONICS FPO [NAN]

52MEDIUM

PCK

PAINCHEK FPO [PCK]

51MEDIUM

Score Breakdown

NAN PCK
Technical
49
43
Catalyst
53
53
Sentiment
50
50
Fundamental
94
51
Momentum
41
28
Risk Gate
40
42

Key Metrics

NAN Metric PCK
$965.5MMarket Cap$23.0M
440KAvg Volume (20d)217K
+6.9%Short InterestN/A
$4.77052-Week High$1.050
$2.96052-Week Low$0.095
-0.3%Daily Change-4.6%
$3.220Reference Price$0.105
+10.1%ROE-383.2%
+9.9%Profit Margin-268.1%

Active Signals

NAN Signals

●MACD momentum is losing steam
●Stochastic is deep in oversold territory — bounce conditions forming
●Below the 200-day average — the long-term trend is still working against it
●Cash positive / operating cashflow positive
●Low P/S ratio (4.7x)
●Moderate revenue growth (+9%)
●Piotroski F-Score strong (8/9, low-confidence approx)
●EPS estimates revised upward (+3pts)

PCK Signals

●RSI drifting toward oversold territory — worth watching
●Bollinger Bands are tightening — volatility is coiling up for a potential breakout
●Trading below both moving averages — the trend is working against this one
●Drifting lower — down 4.5% over the last 5 days
●Below the 200-day average — the long-term trend is still working against it
●Low cash runway (3 quarters) - dilution risk
●Moderate P/S ratio (6.7x)
●Near 52-week low (2% of range)

Ask Scout AI to compare NAN and PCK in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

NAN vs PEB →NAN vs PKY →NAN vs PTX →NAN vs RCE →NAN vs SLD →
NAN Full Analysis → PCK Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).